Forum.
REFERENCES
1. Morita T, Tsuneto S, Shima Y. Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Management, 2002; 24: 447-53.
2. Chater S, Viola R, Paterson J, Jarvis V. Sedation for intractable distress in the dying - a survey of experts. Pall Med, 1998; 12: 255-269.
3. Sales JP. Sedation and terminal care. Eur J Pall Care, 2001; 8: 97-100.
4. Sykes N and Thorns A. The use of opioids and sedatives at the end of life. Lancet Oncology, 2003; 4:312-318.
5. Heyse-Moore L. Terminal restlessness and sedation: a note of caution. Palliative Medicine, 2003; 17: 469.
6. Cowan J, Walsh D. Terminal sedation in palliative medicine – definition and review of the literature. Support Care Cancer, 2001; 9: 403-7
7. Fainsinger R, Waller A, Bercovici M et al. A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Pall Med,
2000; 14: 257-265.
8. McIver B, Walsh D, Nelson K. The use of chlorpromazine for symptom control in dying cancer patients. J Pain Symptom Management, 1994; 9: 341-345.
9. Stone P, Phillips C, Spruyt O, Waight C. A comparison of the use of sedative in a hospital support team and in a hospice. Pall Med, 1997; 11: 140-144.
10. Sykes NP, Thorns A. Sedative use in the last week of life and the implications for end of life decision-making. Arch Int Med, 2003; 163: 341-344.
11. Ventafridda V, Ripamonti C, de Conno F, Tamburini M, Cassileth BR. Symptom prevalence and control during cancer patients' last days of life. J Pall Care, 1990; 6(3): 7-11.
12. Turner K, Chye R, Aggarwal G, Philip J, Skeels A and Lickiss J.N. Dignity in dying: A preliminary study of patients in the last three days of life. J Pall Care, 1996; 12(2): 7-13.
13. Morita T, Tsunoda J, Inoue S, Chihara S. Do hospice clinicians sedate patients intending to hasten death? J Pall Care, 1999; 15(3): 20-23.
14. Chiu TY, Hu W-Y, Lue B-H, Cheng S-Y, Chen C-Y. Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Management, 2001; 21: 467-472.
15. Morita T, Inoue S, Chihara S. Sedation for symptom control in Japan: the importance of intermittent use and communication with family members. J Pain Symptom Management, 1996; 12: 32-38.
16. Fainsinger RL, Landman W, Hoskings M, Bruera E. Sedation for uncontrolled symptoms in a South African hospice. J Pain Symptom Management, 1998; 16: 145-152.
17. Morita T, Tsunoda J, Inoue S, Chihara S. Effects of high dose opioids and sedatives on survival in terminally ill cancer patients. J Pain Symptom Management, 2001: 21: 282-289.
18. Fainsinger RL, de Moissac D, Mancini I, Oneschuk D. Sedation for delirium and other symptoms in terminally ill patients in Edmonton. J Pall Care, 2000; 16(2): 5-10.
19. Fainsinger RL. Use of sedation by a hospital palliative care support team.
J Pall Care, 1998; 14(1): 51-54.
20. Muller-Busch HC, Andres I, Jehser T. Sedation in palliative care - a critical analysis of 7 years experience. BMC Palliat Care. 2003 May 13;2:2.
21. McNamara P, Minton M, Twycross RG. The use of midazolam in palliative care. Pall Med, 1991; 5: 244-249.
22. Amesbury BDW, Dunphy KP. The use of subcutaneous midazolam in the home care setting. Palliative Medicine, 1989; 3:299-301.
23. Bottomley DM, Hanks GCW. Subcutaneous midazolam infusion in palliative care. J Pain Symptom Manage, 1990; 5:259-261.
24. Burke AL, Diamond PL, Hulbert J, et al. Terminal restlessness - its management and the role of midazolam. Med J Aust, 1991; 155:485-487.
25. de Souza E, Jepson BA. Midazolam in terminal care. Lancet, 1998; 1:67-68.
26. Gremaud G, Zulian G. Indications and limitations of intravenous and subcutaneous midazolam in palliative care center. J Pain Symptom Manage, 1998; 15: 331-333.
27. Holdsworth MT, Adams VR, Chavez CM, et al. Continuous midazolam infusion for the management of morphine induced myoclonus. Ann Pharmacother, 1995; 29:25-29.
28. Ramani S, Karnad AB. Long-term subcutaneous infusion of midazolam for refractory delirium in terminal breast cancer. South Med J, 1996; 89:1101-1103.
29. Stirling LC, Kurowska A, Tookman A. The use of phenobarbitone in the management of agitation and seizures at the end of life. J Pain Symptom Manage, 1999; 17:363-368.
30. Moyle J. The use of propofol in palliative medicine. J Pain Symptom Management, 1995; 10: 643-646.
31. Mercadante S, DeConno F, Ripamonti C. Propofol in terminal care. J Pain Symptom Management, 1995; 10: 639-42.
32. Twycross RG, Wilcock A, Charlesworth S, Dickmand A. Palliative Care Formulary 2nd edition, 2002. Radcliffe Medical Press, Abingdon, Oxon.
33. Breitbart W et al. A double-blind trial of haloperidol, chlorpromazine and lorazepam in the treatment of delirium in hospitalised AIDS patients. Am J Psych, 1996; 153:231-237.
Comments